Global Hepatitis A Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
According to APO Research, The global Hepatitis A Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.
Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.
In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
According to APO Research, The global Hepatitis A Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.
Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.
In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCA
- ChangSheng
- Convac
- Inactivated Vaccine
- Live Attenuated Vaccine
- Government Institution
- Private Sector
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Hepatitis A Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Hepatitis A Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Hepatitis A Vaccine Market by Type
1.3.1 Inactivated Vaccine
1.3.2 Live Attenuated Vaccine
1.4 Global Hepatitis A Vaccine Market Size by Type
1.4.1 Global Hepatitis A Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Hepatitis A Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Hepatitis A Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Hepatitis A Vaccine Industry Trends
2.2 Hepatitis A Vaccine Industry Drivers
2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
2.4 Hepatitis A Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Hepatitis A Vaccine Revenue (2019-2024)
3.2 Global Top Players by Hepatitis A Vaccine Sales (2019-2024)
3.3 Global Top Players by Hepatitis A Vaccine Price (2019-2024)
3.4 Global Hepatitis A Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Hepatitis A Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Hepatitis A Vaccine Company, Product Type & Application
3.7 Global Hepatitis A Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hepatitis A Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Hepatitis A Vaccine Tier 1, Tier 2, and Tier
4 HEPATITIS A VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Hepatitis A Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Hepatitis A Vaccine Historic Market Size by Region
4.2.1 Global Hepatitis A Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Hepatitis A Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Hepatitis A Vaccine Forecasted Market Size by Region
4.3.1 Global Hepatitis A Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Hepatitis A Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 HEPATITIS A VACCINE BY APPLICATION
5.1 Hepatitis A Vaccine Market by Application
5.1.1 Government Institution
5.1.2 Private Sector
5.1.3 Other
5.2 Global Hepatitis A Vaccine Market Size by Application
5.2.1 Global Hepatitis A Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Hepatitis A Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Hepatitis A Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Hepatitis A Vaccine Product Portfolio
6.1.5 GSK Recent Developments
6.2 Merck
6.2.1 Merck Comapny Information
6.2.2 Merck Business Overview
6.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Hepatitis A Vaccine Product Portfolio
6.2.5 Merck Recent Developments
6.3 Sanofi
6.3.1 Sanofi Comapny Information
6.3.2 Sanofi Business Overview
6.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments
6.4 Sinovac
6.4.1 Sinovac Comapny Information
6.4.2 Sinovac Business Overview
6.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
6.4.5 Sinovac Recent Developments
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Comapny Information
6.5.2 Zhejiang Pukang Business Overview
6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Comapny Information
6.6.2 Changchun Institute of Biological Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Comapny Information
6.7.2 KM Biologics Business Overview
6.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments
6.8 IMBCA
6.8.1 IMBCA Comapny Information
6.8.2 IMBCA Business Overview
6.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
6.8.5 IMBCA Recent Developments
6.9 ChangSheng
6.9.1 ChangSheng Comapny Information
6.9.2 ChangSheng Business Overview
6.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
6.9.5 ChangSheng Recent Developments
6.10 Convac
6.10.1 Convac Comapny Information
6.10.2 Convac Business Overview
6.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Convac Hepatitis A Vaccine Product Portfolio
6.10.5 Convac Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Hepatitis A Vaccine Sales by Country
7.1.1 North America Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Hepatitis A Vaccine Sales by Country (2019-2024)
7.1.3 North America Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Hepatitis A Vaccine Market Size by Country
7.2.1 North America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Hepatitis A Vaccine Market Size by Country (2019-2024)
7.2.3 North America Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Hepatitis A Vaccine Sales by Country
8.1.1 Europe Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Hepatitis A Vaccine Sales by Country (2019-2024)
8.1.3 Europe Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Hepatitis A Vaccine Market Size by Country
8.2.1 Europe Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Hepatitis A Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Hepatitis A Vaccine Sales by Country
9.1.1 Asia-Pacific Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Hepatitis A Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Hepatitis A Vaccine Market Size by Country
9.2.1 Asia-Pacific Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Hepatitis A Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Hepatitis A Vaccine Sales by Country
10.1.1 Latin America Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Hepatitis A Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Hepatitis A Vaccine Market Size by Country
10.2.1 Latin America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Hepatitis A Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Hepatitis A Vaccine Sales by Country
11.1.1 Middle East and Africa Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Hepatitis A Vaccine Market Size by Country
11.2.1 Middle East and Africa Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Hepatitis A Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Hepatitis A Vaccine Value Chain Analysis
12.1.1 Hepatitis A Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Hepatitis A Vaccine Production Mode & Process
12.2 Hepatitis A Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Hepatitis A Vaccine Distributors
12.2.3 Hepatitis A Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Hepatitis A Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Hepatitis A Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Hepatitis A Vaccine Market by Type
1.3.1 Inactivated Vaccine
1.3.2 Live Attenuated Vaccine
1.4 Global Hepatitis A Vaccine Market Size by Type
1.4.1 Global Hepatitis A Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Hepatitis A Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Hepatitis A Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Hepatitis A Vaccine Industry Trends
2.2 Hepatitis A Vaccine Industry Drivers
2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
2.4 Hepatitis A Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Hepatitis A Vaccine Revenue (2019-2024)
3.2 Global Top Players by Hepatitis A Vaccine Sales (2019-2024)
3.3 Global Top Players by Hepatitis A Vaccine Price (2019-2024)
3.4 Global Hepatitis A Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Hepatitis A Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Hepatitis A Vaccine Company, Product Type & Application
3.7 Global Hepatitis A Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hepatitis A Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Hepatitis A Vaccine Tier 1, Tier 2, and Tier
4 HEPATITIS A VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Hepatitis A Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Hepatitis A Vaccine Historic Market Size by Region
4.2.1 Global Hepatitis A Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Hepatitis A Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Hepatitis A Vaccine Forecasted Market Size by Region
4.3.1 Global Hepatitis A Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Hepatitis A Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 HEPATITIS A VACCINE BY APPLICATION
5.1 Hepatitis A Vaccine Market by Application
5.1.1 Government Institution
5.1.2 Private Sector
5.1.3 Other
5.2 Global Hepatitis A Vaccine Market Size by Application
5.2.1 Global Hepatitis A Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Hepatitis A Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Hepatitis A Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Hepatitis A Vaccine Product Portfolio
6.1.5 GSK Recent Developments
6.2 Merck
6.2.1 Merck Comapny Information
6.2.2 Merck Business Overview
6.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Hepatitis A Vaccine Product Portfolio
6.2.5 Merck Recent Developments
6.3 Sanofi
6.3.1 Sanofi Comapny Information
6.3.2 Sanofi Business Overview
6.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments
6.4 Sinovac
6.4.1 Sinovac Comapny Information
6.4.2 Sinovac Business Overview
6.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
6.4.5 Sinovac Recent Developments
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Comapny Information
6.5.2 Zhejiang Pukang Business Overview
6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Comapny Information
6.6.2 Changchun Institute of Biological Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Comapny Information
6.7.2 KM Biologics Business Overview
6.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments
6.8 IMBCA
6.8.1 IMBCA Comapny Information
6.8.2 IMBCA Business Overview
6.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
6.8.5 IMBCA Recent Developments
6.9 ChangSheng
6.9.1 ChangSheng Comapny Information
6.9.2 ChangSheng Business Overview
6.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
6.9.5 ChangSheng Recent Developments
6.10 Convac
6.10.1 Convac Comapny Information
6.10.2 Convac Business Overview
6.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Convac Hepatitis A Vaccine Product Portfolio
6.10.5 Convac Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Hepatitis A Vaccine Sales by Country
7.1.1 North America Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Hepatitis A Vaccine Sales by Country (2019-2024)
7.1.3 North America Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Hepatitis A Vaccine Market Size by Country
7.2.1 North America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Hepatitis A Vaccine Market Size by Country (2019-2024)
7.2.3 North America Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Hepatitis A Vaccine Sales by Country
8.1.1 Europe Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Hepatitis A Vaccine Sales by Country (2019-2024)
8.1.3 Europe Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Hepatitis A Vaccine Market Size by Country
8.2.1 Europe Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Hepatitis A Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Hepatitis A Vaccine Sales by Country
9.1.1 Asia-Pacific Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Hepatitis A Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Hepatitis A Vaccine Market Size by Country
9.2.1 Asia-Pacific Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Hepatitis A Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Hepatitis A Vaccine Sales by Country
10.1.1 Latin America Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Hepatitis A Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Hepatitis A Vaccine Market Size by Country
10.2.1 Latin America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Hepatitis A Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Hepatitis A Vaccine Sales by Country
11.1.1 Middle East and Africa Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Hepatitis A Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Hepatitis A Vaccine Market Size by Country
11.2.1 Middle East and Africa Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Hepatitis A Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Hepatitis A Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Hepatitis A Vaccine Value Chain Analysis
12.1.1 Hepatitis A Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Hepatitis A Vaccine Production Mode & Process
12.2 Hepatitis A Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Hepatitis A Vaccine Distributors
12.2.3 Hepatitis A Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
